UUID:F47FE6AB-1095-45DD-8CEF-33363FAR9Fe52Fa
TCGA- CC- -A9FS- 01A- PR

III II II I IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII IIIIII IIIIIIII I ‘ ‘
IIII |III|||||||||I|IIII|IIIIIIIIIIIIIIIIIIIIIIIIIIIII||||| Illdlllallllle 2
III IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII _,6 ' 'i _. W'

Clinical Case Report m0 5
(For Collection of Cancerous Tissue) W W

453:»; Mum (£53258,
@34/71/4

I personally informed this patient that a specimen(s) would be collected to be used for research
purposes. I reviewed the RESEARCH SUBJECT INFORMATION AND CONSENT
FORM with the patient and answered any questions the patient had. The patient then signed the

consent form as a free and voluntary act. A copy of this informed consent document will be retained at
our institution.

 

 

Name of Physician or Study Coordinator V .gnature . Date h

 

IClinicaI Informationj

Race T

El Single Married "»
D Divorced El Widow Blood Pressure Heart Rate

 

 

     

 

 

255* ' HISTORY OF PRESENT ILLNESS '52-'21 5 1
Chief Complamts- ’f (4&1 a? £941qu J 19 a W? ) I3: 2v
Symptoms: \N 9/ka £093 :
Clinical Findings: :2

 

 

Performance Scale (Karnofsky Score):

CI 100 Asymptomatic CI 80-90 Symptomatic but Fully Ambulatory , 0-70 Symptomatic, in bed less than 50% of day
II] 40-50 Symptomatic, in bed more than 50% of day, but n t bed ridden C] 20-30 Bed Ridden

 

 

 

o s~26 ~
DOSE

 

.> ”SQ-W1, i' ,

tr.» .~

. 3“: ",1?

Disease Disorder

I,,-t-
.‘l

Treatment

‘4“. :9

i,~‘;,

 

"l“ _. “(ls-1’1

Status

 

   

   

 

 

 

 

. ii I, I. 6 '_ BIGYNHISTOR , . .
Menopausal Status Date of First Menses # of PreLnancles
D Pro-menopausal
CI Peri-Menopausal Date of Last Menses # of Live Births
El Post-menopausal

 

 

 

 

Birth Control: [I Condom [J Oral Contraceptive

D Other:

0 lUD

 

El Hormone Replacement

Therapy:

 

 

Current
El YES

Current

TYPE

Environmental Hazards:

Alcohol Consum

Drinks

Duration

Duration
D NO “

Use

Current Status

Duration

E] YES NO

 

 

55;; M

i‘ r
' i ' " ,i "(.37

Relative

  
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

~g “ii-33k: ' ’27.} LABIDAEPA‘“
Test Result I Date Iii-2:24 Test Result Date
HIV Wegative El Positive: W DEA El Negative [3 Positive:
Hep B ﬁNegative :1 Positive: l / Ml CA 15-3 El Negative El Positive:
Hep C @Negative D Positive: CA 19-9 1: ﬁgative 13 Positive:
AFP ‘D Negative 1:! Positive: PSA El Negative III Positive:
Other: E] Negative D Positive: Other: D Negative El Positive:
B/T Cell Markers:

 

 

 

 

Results

Ultrasound
x-
CT

Clinical Di

Location of Involved L Nodes Location of

Clinical
T N 0 Stage:

 

 

ﬁreatment Information]

Procedure

Prima Tumor
Detailed

Extension of

L Nodes

Location of L
Palpable, Non-Dissected Lymph Nodes ’

Dissected Lymph Nodes
Distant Metastasis

Detailed Location

Su icai Sta
N M

"1m.“ ,
, a, ‘

reatment Dose .Route

 

Distant Metastasis

Date

 

Pathology Form

 

[Specimen Informatioﬂ

Collected by: _ _,_ Date:

Preserved by: _ A __ Date:

Parafﬁn Block
Normal

Frozen Blood/Serum/Piasma
Diseased

Normal Diseased Normal

2

me to LN2 Time to Formaiin

min

Time to LN2

"' 5’2‘Iifﬁsisié“*'sl’ - ~ i“ \
Tumor
Size
X cm

Nodes
# Examined

n

Location

Distant Metastasis
Detailed Location

Patho icai
pT Z N 0 M 1‘)
Notes: '

midi“: 1

Extension of Tumor

Stage: 53:.

Time
Time:

-: .-. - t m i ~ ', L“
:-I‘:»:,,£;i- $423! w ,

. (3 art; , i «
Slide
Diseased Normal

Distance to NAT
cm

# Metastasized

 

 

 

Consolidated Pathology Diagnosis

1

 

 

 

w
Histological Diagnosis:

’ Gndo- 2
M. Jam/W hr he
Comments: //

bulk——

 

 

 

 

Director. Research Pathology

Criteria A) l .3 I
INTEGRATED REPORT OF FINDINGS W mm AND PATHOLOGISI'S "

 

